Compare CRBG & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRBG | BAX |
|---|---|---|
| Founded | 1957 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 13.9B |
| IPO Year | 2022 | 1994 |
| Metric | CRBG | BAX |
|---|---|---|
| Price | $34.97 | $22.94 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 9 |
| Target Price | ★ $35.15 | $21.00 |
| AVG Volume (30 Days) | 3.3M | ★ 4.8M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.56% | 0.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | ★ $18,481,000,000.00 | $11,244,000,000.00 |
| Revenue This Year | $16.24 | $1.96 |
| Revenue Next Year | $5.65 | $2.22 |
| P/E Ratio | ★ N/A | $109.62 |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $22.19 | $15.73 |
| 52 Week High | $35.64 | $30.00 |
| Indicator | CRBG | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 64.47 | 30.33 |
| Support Level | $29.75 | $21.28 |
| Resistance Level | N/A | $23.62 |
| Average True Range (ATR) | 0.75 | 0.78 |
| MACD | 0.09 | -0.32 |
| Stochastic Oscillator | 80.30 | 6.67 |
Corebridge Financial Inc provides retirement solutions and insurance products in the United States, offering fixed, fixed index, and registered index-linked annuities with optional benefits, including lifetime income guarantees and death benefits, distributed through an extensive platform. The company operates through the Individual Retirement, Group Retirement, Life Insurance, Institutional Markets, and Corporate and Other segments. Individual Retirement consists of fixed, fixed index, and registered index-linked annuities, while Group Retirement includes recordkeeping and plan administrative services. The company operates in North America and internationally, with overall revenue coming from North America.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.